SCHEMBL4417423

SCHEMBL4417423

CCCCNC(=O)Oc1cc(-c2ccc(OC)c(OC)c2)n(CC2CCCCC2)c1C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MGLL Q99685 2/20 0.43
CFTR P13569 1/20 0.39
PDE4B Q07343 3/20 0.39
HTR2A P28223 3/20 0.39
HTR2C P28335 3/20 0.39
SLC6A4 P31645 3/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
PDE4A P27815 1/20 0.38
PDE4C Q08493 1/20 0.38
PDE4D Q08499 1/20 0.38
TLR8 Q9NR97 1/20 0.38
TLR7 Q9NYK1 1/20 0.38
TP53 P04637 1/20 0.38
QPCT Q16769 1/20 0.37
PLA2G2A P14555 1/20 0.37
ALDH1A1 P00352 1/20 0.37
LMNA P02545 1/20 0.37
MAPT P10636 1/20 0.37
CRHBP P24387 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4423636 0.90 ALDH1A1 (0.47) MGLLHTR2AHTR2CSLC6A4MEN1
SCHEMBL4423695 0.89 HTR2A (0.41) MGLLHTR2AHTR2CSLC6A4MEN1
SCHEMBL4429632 0.88 ALDH1A1 (0.43) HTR2AHTR2CSLC6A4PLA2G2AALDH1A1
SCHEMBL4423191 0.88 NCEH1 (0.41) MGLLHTR2AHTR2CSLC6A4TP53
SCHEMBL4417093 0.87 MAPT (0.43) MGLLHTR2AHTR2CSLC6A4ALDH1A1
SCHEMBL4418725 0.87 HTR2A (0.46) HTR2AHTR2CSLC6A4
SCHEMBL3923363 0.86 HTR2A (0.51) CFTRHTR2AHTR2CSLC6A4MEN1
SCHEMBL4426602 0.86 PLA2G2A (0.42) MGLLPLA2G2AALDH1A1
SCHEMBL4422341 0.86 NCEH1 (0.43) MGLLHTR2AHTR2CSLC6A4ALDH1A1
SCHEMBL4425161 0.85 RAB9A (0.43) HTR2AHTR2CSLC6A4MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1583742-B1 CB 1 RECEPTOUR INVERSE AGONISTS HOFFMANN LA ROCHE (CH) 2009-12-02 EP claimed